Radcliffe Labs accelerates integrated diagnostics strategy with acquisition of Megavision Diagnostics
Samira Vishwas August 12, 2026 07:24 AM

Expansion of diagnostic services with two state-of-the-art MRI centers in Pune
A first strategic investment in Western India, a significant step towards strengthening integrated diagnostics capabilities

Mumbai: Radcliffe Labs, one of India's fastest growing omnichannel diagnostic service providers, has announced the acquisition of Pune-based Megavision Diagnostics Centre. The acquisition is an important step in Radcliffe Labs' long-term strategy to build an integrated diagnostics platform, strengthening the company's integrated diagnostics capabilities by bringing together advanced imaging and pathology services on one trusted platform.

Health Update: 45 degree bone cut and straight back! New life for a young man bent with ankylosing spondylitis

The acquisition will connect Megavision Diagnostics' two state-of-the-art MRI centers in Pune's Pimpri-Chinchwad area to Radcliffe's existing pathology network, providing patients with a more comprehensive range of diagnostic services in one place. Serving for over two decades, Megavision has won the trust of patients as well as medical professionals for its clinical excellence and quality imaging services. The acquisition will bring together Megavision's strong local heritage and Radcliffe Labs' technology-enabled diagnostic network to lay a stronger foundation for the expansion of integrated diagnostic services in Western India. Additionally, Radcliffe Labs will retain all of MegaVision's staff, ensuring continuity of patient care and a more accessible and comprehensive diagnostic experience.

Leveraging on its strong pathology network in Western India, Radcliffe Labs is now expanding its integrated diagnostics capabilities to provide more comprehensive diagnostic services. The acquisition of Megavision Diagnostics lays the foundation for a connected diagnostics ecosystem that brings together advanced imaging and pathology services. Also, this marks the beginning of the company's long-term expansion strategy to strengthen its presence in Western India through strategic partnerships and acquisitions.

The acquisition also furthers Radcliffe Labs' strategy to strengthen its diagnostics capabilities through selective partnerships and acquisitions in key markets in the country. Over the past year, the company has acquired Prime Sonography and Diagnostic Center (Kota) and Sarvodaya Diagnostics (Ajmer) in Rajasthan, which are now operating under the name Radcliffe Medicenter Imaging and Labs. These acquisitions are emblematic of the company's long-term strategy of combining regional expertise with a national-level diagnostic network.

Founded more than two decades ago Megavision Diagnostics Dr. Kedar Prabhakar Bhate Under his leadership, the diagnostic imaging field has gained remarkable trust and reputation. Even after the acquisition, Dr. Bhate will continue to lead MegaVision Radcliffe Labs and work with Radcliffe's clinical board to expand integrated diagnostic services in and around Pune.

Dheeraj Jain, Chairman and Founder of Radcliffe Labs said, “The healthcare sector is rapidly moving towards integrated services, where the role of diagnostics is becoming more important for more accurate medical decisions and better health outcomes. Our long-term vision is to build the most trusted integrated diagnostics network in India by combining clinical excellence, technology and regional expertise. We are committed to further facilitate high-quality and comprehensive diagnostic services across the country through every strategic partnership.”

Aditya Kandoi, founder and CEO of Radcliffe Labs Said, “Pune is one of the fastest growing healthcare markets in India, with citizens' awareness of quality diagnostic services steadily increasing. By strengthening our presence in the city, combining Megavision's expertise in radiology with Radcliffe's pathology network will provide patients with an easier and more seamless diagnostic experience. We believe the future of diagnostics lies in integrated healthcare, where pathology and radiology come together to ensure faster diagnosis, more effective medical decisions and simpler healthcare for patients.” will do.”

The risk of cholesterol increases due to the wrong oil eaten in the daily diet! This oil is best for heart health

Founder and Director of Megavision Diagnostics Dr. Kedar Prabhakar Bhate said, “Megavision Diagnostics' journey has been built on trust, relationships and an unwavering commitment to quality healthcare. Becoming part of the Radcliffe Labs family is an important milestone in our journey. I am confident that the same values ​​of patient-centric service and clinical excellence will enable us to reach out to more people. We will also continue to build on the trust and quality we have nurtured over the past two decades.”

© Copyright @2026 LIDEA. All Rights Reserved.